紐爾真檢測 NEOG 深 滬
等待開盤 08-21 09:30:00 美东时间
11.83
-0.320
-2.63%
華盛通- 最 高12.15
- 今 開11.99
- 成交量 136.67万股
- 最 低 11.725
- 昨 收 12.15
- 總市值 25.80亿
- 52周最高 12.85
- 市盈率 靜 --
- 換手率 0.63%
- 52周最低 4.90
- 委 比 -99.54%
- 總股本 2.18亿
- 歷史最高 48.85
- 量 比 0.82
- 振 幅 3.50%
- 歷史最低 3.8701
- 每 手 1
- 風險率 1.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sera Prognostics appoints Scott Gleason as CFO, effective Aug. 31
Sera Prognostics (SERA) announced on Wednesday that Scott Gleason will become CFO, effective August 31, 2026. Gleason has more than 25 years of healthcare, diagnostics, and capital markets experience ...
08-20 04:38
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Corbus Pharmaceuticals reported progress in its oncology and obesity pipeline, obtaining FDA clearance for the registrational study of CRB-701 in oropharyngeal cancer and completing the last patient visit in the CANYON-1 trial of CRB-913 for obesity. The company also appointed new leadership to strengthen its team. Financially, Corbus reported a net loss of $35 million for the second quarter, with $117.9 million in cash on hand.
08-06 12:00
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Piper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13
Piper Sandler analyst David Westenberg reiterates Neogen (NASDAQ:NEOG) with a Neutral and raises the price target from $11 to $13.
08-04 00:02
Neogen’s Evolving Business Model Keeps Internal Controls a Key Financial Risk
Neogen (NEOG) has disclosed a new risk, in the Accounting & Financial Opera...
08-01 14:01
Neogen shares are trading higher after the company reported better-than-expected Q4 financial results.
Neogen shares are trading higher after the company reported better-than-expected Q4 financial results.
07-31 01:52
Neogen Sees Q1 Sales $207.000M-$209.000M vs $204.710M Est
Neogen (NASDAQ:NEOG) sees Q1 sales of $207.000 million-$209.000 million vs $204.710 million analyst estimate.
07-30 19:03
Neogen将于7月30日发布2026财年第四季度财报
食品安全与动物健康检测企业Neogen周一宣布，将于2026年7月30日（星期四）美股盘前发布2026财年第四季度及全年财务业绩。届时公司管理层将召开电话会...
07-20 21:46
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
Freenome Holdings, Inc. announced the closing of its business combination with Perceptive Capital Solutions Corp. and will begin trading on the Nasdaq Capital Market under the ticker symbol "FRNM" on July 21, 2026. The combined company, Freenome, Inc., raised over $300 million through a PIPE led by Perceptive Advisors and RA Capital, along with funds from PCSC's trust account. The capital will support Freenome's cancer screening portfolio, AI/ML-...
07-20 20:01
Zoetis, Neogen deal draws antitrust concerns in Australia
The Australian Competition and Consumer Commission said on Friday that Zoetis’ (ZTS) $160M deal to buy the animal genomics business of Neogen (NEOG) should be subject to an in-depth review due to anti...
07-17 22:38
